解读AP1M2在调节肝细胞癌生长和通过JNK/ErK信号通路控制的移动性方面的影响
Huan Wang1, Xin Xie1, Minwei Du1
1Department of Gastroenterologya Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, No.250 Changgang East Road, Haizhu District, Guangzhou 510000, China.
增加AP1M2表达与肝细胞癌 (HCC) 的预后较差有关. 这项研究揭示了AP1M2促进HCC细胞生长和迁移,突出了其作为预后标记物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 是一种流行于消化系统的恶性瘤,存活率较低,发病因子不明.
- AP1M2在HCC进展中的作用及其潜在的分子机制需要进一步阐明.
研究的目的:
- 为了研究HCC中AP1M2的表达水平.
- 为了确定HCC患者AP1M2的预后值.
- 阐明AP1M2影响HCC进展的分子机制.
主要方法:
- 利用GEO,XENA和TCGA数据库进行基因表达分析和途径识别.
- 进行了体外测定 (EdU,CCK-8,殖民地形成,Transwell) 以评估AP1M2对HCC细胞增殖和迁移的影响.
- 进行了西斑分析,以检查AP1M2对包括JNK/ERK在内的信号通路的影响.
主要成果:
- 在HCC组织中,AP1M2mRNA水平显著升高 (P<0.001).
- 较高的AP1M2表达与HCC患者的整体存活率 (OS) 较差相关 (P<0.019),并被确定为独立的预后因素.
- AP1M2促进HCC细胞的增殖和迁移,激活JNK/ERK信号通路.
结论:
- AP1M2 作为 HCC 的潜在预后分子标志物.
- AP1M2显著影响HCC细胞的增殖和迁移.
- 在AP1M2介导的HCC调控中,JNK/ERK信号通路至关重要.
更多相关视频
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Abnormal Proliferation
The JAK-STAT Signaling Pathway
